Neurologic Disorders News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Neurologic disorders may be linked to brain's immune system - Genetic Literacy Project



Genetic Literacy Project
 
Neurologic disorders may be linked to brain's immune system 
Genetic Literacy Project
Sometimes probing what we thought we knew to find cracks in our theories leads to whole new avenues of scientific understanding. Take for example recent experiments on electrons. Researchers attempted to find asymmetries in the sphericity of these ...

 


Neurologic Diseases Found to Be the Largest Cause of Disability Worldwide - LWW Journals



Neurologic Diseases Found to Be the Largest Cause of Disability Worldwide 
LWW Journals
In an analysis of data for 195 countries, the Global Burden of Disorders Study Group found that neurological disorders caused 250.7 million disability-adjusted life years (DALYs) in 2015, an increase of 7.4 percent from 1990. Stroke was reported to be ...

 


Aptinyx to Present Preclinical Data for NMDA Receptor Modulators in Neurologic Disorders at Neuroscience 2017 - Markets Insider



Aptinyx to Present Preclinical Data for NMDA Receptor Modulators in Neurologic Disorders at Neuroscience 2017 
Markets Insider
EVANSTON, Ill., Nov. 14, 2017 /PRNewswire/ -- Aptinyx Inc., a clinical-stage biopharmaceutical company developing transformative therapies for challenging neurologic disorders, today announced the presentation of results from several studies of novel ...

and more » 


In the Clinic-Conversion Disorders: New Insights into Diagnosing Functional Acute Neurological Disorders in Children - LWW Journals



In the Clinic-Conversion Disorders: New Insights into Diagnosing Functional Acute Neurological Disorders in Children 
LWW Journals
KANSAS CITY, MO?A thorough neurological exam may be more effective in diagnosing functional acute neurological disorders in children than ordering diagnostic tests, according to a retrospective examination of medical charts at Children's Hospital of ...

 


In Preclinical Data, Aptinyx's NYX-2925 Shows Potential to Decrease Symptoms of Sleep Disruption Caused by Sleep ... - Sleep Review



In Preclinical Data, Aptinyx's NYX-2925 Shows Potential to Decrease Symptoms of Sleep Disruption Caused by Sleep ... 
Sleep Review
Aptinyx Inc, a clinical-stage biopharmaceutical company developing therapies for challenging neurologic disorders, presented results from several studies of novel N-methyl-D-aspartate (NMDA) receptor modulators in models of neuropathic pain, ...

 


Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Given New $48.00 Price Target at Noble Financial - The Ledger Gazette



Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) Given New $48.00 Price Target at Noble Financial 
The Ledger Gazette
The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic disorders. It offers a platform based on an understanding of time dependent biologic effects of disease activity and drug response to ...
Cutter & Company Brokerage Has Lowered By $2.41 Million Its Rgc Resources (RGCO) Stake; 9 Analysts Bullish ... NormanObserver.com

all 22 news articles » 


Speak Up - LWW Journals (blog)



Speak Up 
LWW Journals (blog)
Speak Up. Enjoy essays and poetry by people living with neurologic disorders and their caregivers. Readers can also find letters to the editor. Friday, October 27, 2017. Persistence Pays Off. Email to a Friend. Friend's E-mail is Invalid. Your Name ...

 


Vitamin D Deficiency and Cognitive Functioning in Psychotic Disorders - Psychiatric Times



Psychiatric Times
 
Vitamin D Deficiency and Cognitive Functioning in Psychotic Disorders 
Psychiatric Times
Subjects had blood drawn for 25-hydroxy-vitamin D levels and underwent cognitive assessments in the same season. They spoke Norwegian as their primary language or were educated in Norway. Subjects with traumatic brain injury, neurologic disorders, ...

 


Biohaven Pharmaceuticals Reports Third Quarter 2017 Financial And Business Results - Markets Insider



Biohaven Pharmaceuticals Reports Third Quarter 2017 Financial And Business Results 
Markets Insider
Equally important, beyond migraine, we have made strategic additions to our clinical programs in both common and rare neurologic disorders and cancer during the fourth quarter, from which we expect to receive additional topline results in 2018. Our ...

and more » 


Health Canada Approves Cuvposa to Treat Severe Drooling in Kids with Cerebral Palsy - Cerebral Palsy News Today



Cerebral Palsy News Today
 
Health Canada Approves Cuvposa to Treat Severe Drooling in Kids with Cerebral Palsy 
Cerebral Palsy News Today
?Cuvposa is an important advancement in the treatment of chronic severe drooling in children with neurologic disorders.? Merz North America, one of Pediapharm's partners, acquired Cuvposa in 2012. Although Cuvposa already had U.S. approval, Merz ...